Objective To assess routine application and clinical value of definitive urine drug monitoring
(UDM) for drug detection, inconsistent drug use, and prescription adherence, along with a …

Objective. This study investigates the frequency at which quantitative results provide
additional clinical benefit compared to qualitative results alone. A comparison between …

Objective To develop consensus recommendations on urine drug monitoring (UDM) in
patients with chronic pain who are prescribed opioids. Methods An interdisciplinary group of …

Objective: To determine the current status of performing urine drug tests (UDTs) for
monitoring chronic pain therapy, with an emphasis on their use in opioid treatment and the …

The widespresad use of opioids to treat chronic nonmalignant pain has resulted in a parallel
increase in misuse, abuse, addiction, overdose, and diversion. Because self-reporting is …

Background: Therapeutic use, overuse, abuse, and diversion of controlled substances in
managing chronic non-cancer pain continues to be an issue for physicians and patients. It …

Background: The precise role of urine drug testing (UDT) in the practice of pain medicine is
currently being defined. Confusion exists as to best practices, and even to what constitutes …

Background: Urine drug testing is used by health care providers to determine a patient's
compliance to their prescribed regimen and to detect non-prescribed medications and illicit …

Background: The challenge for physicians in treating chronic pain with opioids is to
eliminate or significantly curtail abuse of controlled prescription drugs while assuring proper …

Background It can be challenging to successfully monitor medication compliance in pain
management. Clinicians and laboratorians need to collaborate to optimize patient care and …